Globenewswire

Search documents
Gain Therapeutics Receives Australian Approval of Phase 1b Dosing Extension and Reports Positive Independent Data Monitoring Committee Recommendation
Globenewswire· 2025-09-04 12:00
Ongoing Phase 1b trial of GT-02287 to be extended by an additional nine months for participants who enrolled in the original three-month study design The independent data monitoring committee (DMC) met recently and recommended to continue the study with no changes to study design BETHESDA, Md., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric ...
Gauzy Ltd. to Attend B. Riley Securities Consumer & TMT Conference
Globenewswire· 2025-09-04 12:00
NEW YORK and TEL AVIV, Israel, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Gauzy Ltd. (Nasdaq: GAUZ), a global leader in vision and light control solutions, today announced that its senior management will attend the B. Riley Securities Consumer & TMT Conference on Wednesday, September 10, 2025 in New York. About Gauzy Gauzy Ltd. is a fully-integrated light and vision control company, focused on the research, development, manufacturing, and marketing of vision and light control technologies that are developed to supp ...
Cerence AI and SiMa.ai Partner to Power Next-Gen Conversational AI at the Edge
Globenewswire· 2025-09-04 12:00
AI industry leaders join forces to unlock intelligent, low-power voice interaction for automotive applications SUMMARY AND KEY POINTS: Cerence AI and SiMa.ai partner to run CaLLM Edge on SiMa’s Modalix MLSoC, bringing advanced, low-power conversational AI to vehicles.This partnership allows OEMs to deliver an improved user experience with real-time, multi-modal interaction.The solution will debut at IAA Mobility 2025, with a live demo of CaLLM Edge running on SiMa.ai hardware. MUNICH and BURLINGTON, Mass., ...
Kane Biotech to Present revyve® Clinical Data at Symposium on Advanced Wound Care (SAWC) Fall Conference
Globenewswire· 2025-09-04 12:00
Clinical data to be presented demonstrates wound healing in complex wounds that were over two years oldWINNIPEG, Manitoba, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announces that Interim Chief Executive Officer, Dr. Robert Huizinga, will be presenting at the Symposium on Advanced Wound Care (“SAWC”) Fall conference taking place from September 3-6, 2025 in Las Vegas, Nevada. US FDA 510(k) cleared revyve Antimicrobial Wound Gel and revyv ...
Viasat Announces ViaSat-3 F2 Scheduled to Launch in October, Expected to More Than Double Viasat’s Bandwidth Capacity
Globenewswire· 2025-09-04 12:00
ViaSat-3 F2 dynamic beam forming capabilities will deliver extensive benefits to customers in the highest demand places, with anticipated service entry in early 2026 Viasat’s ultra-high-capacity constellation is designed to meet the increasing demand for resilient, global satellite communications from commercial mobility and defense customers CARLSBAD, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Viasat, Inc. (NASDAQ: VSAT), a global leader in satellite communications, today announced that the ViaSat-3 Flight ...
Siebert Financial Appoints Daniel M. Ondeck as Head of Institutional Sales
Globenewswire· 2025-09-04 12:00
Daniel M. Ondeck Daniel M. Ondeck joins Siebert Financial as Head of Institutional Sales. MIAMI and NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Siebert Financial Corp. (Nasdaq: SIEB) announced that Daniel M. Ondeck has joined the firm as Head of Institutional Sales. Based in Washington, D.C., he will lead institutional client coverage and distribution across sector verticals and work closely with Siebert’s investment bankers on origination and execution. Mr. Ondeck brings more than two decades of exper ...
StoneX Acquires Right Corp, Expanding Global Trading Capabilities to Include Wholesale Meat Supply and Distribution
Globenewswire· 2025-09-04 12:00
NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- StoneX Commodity Solutions (SCS), a subsidiary of StoneX Group Inc. (NASDAQ: SNEX) ("StoneX"), announced today the completion of its acquisition of Right Corporation, a Bozeman, MT physical meat-trading company. The acquisition enhances StoneX’s global trading capabilities, extends Right Corporation’s market reach and capitalizes the company for growth. With StoneX’s support, Right Corporation intends to build on relationships with existing suppliers, traders and ...
PodcastOne Grows to 207 Total Shows with the Addition of Beach Too Sandy, Water Too Wet, Acquires the Exclusive Sales Rights to Notsam Wrestling in Multi-Year Deals
Globenewswire· 2025-09-04 12:00
Network Ranked 9th Largest US Podcast Distributor with Over 4 Billion All-Time DownloadsLOS ANGELES, Sept. 04, 2025 (GLOBE NEWSWIRE) -- PodcastOne (NASDAQ: PODC), a leading publisher and podcast sales network, announced today that it has entered into a multi-year agreement for the exclusive sales and distribution rights for Beach Too Sandy, Water Too Wet hosted by siblings Xandy and Christine Schiefer and has expanded its relationship with the Sam Roberts hosted Notsam Wrestling acquiring the exclusive sale ...
Apollo to Present at the Bank of America 30th Annual Financials CEO Conference
Globenewswire· 2025-09-04 12:00
NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Apollo (NYSE: APO) today announced that Jim Zelter, President of Apollo Global Management, will participate in a fireside chat at the Bank of America 30th Annual Financials CEO Conference on Tuesday, September 16, 2025 at 6:00 am EDT. A live webcast of the event will be available on Apollo’s Investor Relations website at ir.apollo.com. For those unable to join live, a replay will be available shortly after the event. About Apollo Apollo is a high-growth, global a ...
Grace Therapeutics Announces Presentation at The H.C. Wainwright 27th Annual Global Investment Conference
Globenewswire· 2025-09-04 12:00
PRINCETON, N.J., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, novel, injectable formulation of nimodipine being developed for IV infusion to address significant unmet medical needs in aSAH patients, today announced that it will be featured as a presenting company at the H.C. Wainwright 27th Annual Global Investment Conference, being held virtually and in person September 8– ...